{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:15:56Z","timestamp":1779340556110,"version":"3.51.4"},"reference-count":0,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[1991,7,1]],"date-time":"1991-07-01T00:00:00Z","timestamp":678326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1991,7]]},"abstract":"<jats:p>\n                    The production of immunoglobulin capable of neutralizing the infectivity of a virus represents one of the most remarkable molecular accomplishments of the host's available immune defenses. It should be no surprise that a virus that has existed in the parenchyma of the immune system has evolved as an equally dynamic molecule (i.e., viral envelope) for survival. Neutralizing immunoglobulin (Ig) can best serve the host under conditions where the invading pathogen requires a well\u2010defined cell\u2010free state for establishing an infection or transmission. Evidence for a controlling and therefore protective role of neutralizing Ig against lentiviruses has been defined in natural and experimental infections with equine infectious anemia virus of ungulate members in the family equidae. Rapid replication of the virus immediately after infection and its release in a cell\u2010free state leads to the production of neutralizing Ig and subsequent control of the primary viremia. A similar cause\u2010effect relationship exists in humans between the high\u2010titered viremia, observed shortly after HIV\u20101 infection, and the subsequent production of neutralizing Ig. Partially controlling this acute stage of viral replication by neutralizing Ig and thus preventing an otherwise acute form of immunosuppression or immune complex disease may be viewed paradoxically as a survival property of the virus. Immunologically mediated control, in a Darwinian sense, selects for viruses that have optimized the parameters of longevity and transmission from host to host. This paradox of neutralization in HIV\u20101 infection appears to be mediated by the convergence of structural and functional roles of the third variable domain (V3) of the external envelope glycoprotein. During infection or envelope\u2010based vaccination, antibody to this cross\u2010reactive, immunodominant epitope dominates the antigenic repertoire. Once this occurs, the host is less able to respond to emerging viruses containing closely related V3 structures. Thus a relatively restricted clonal\u2010dominance of the neutralization response results. The V3 domain, apparently in concert with the rest of the molecule, provides an epitope that can tolerate and utilize its conformational flexibility to allow immune escape while maintaining its functional role in infectivity. Sixteen other putative epitopes have been described as being involved in the induction of neutralizing Ig. Currently the biologically functional role of neutralizing Ig to these other epitopes are complicated by a prior lack of knowledge and appreciation of the in vitro variables affecting their measurements. Thus it appears that the mechanisms of neutralization, the immunologic complexities of the viral envelope, and the design of in vitro assays to more accurately reflect in vivo conditions should greatly improve our future chances of designing, identifying, and eliciting protective immune responses through vaccination.\u2014Nara, P. L.; Garrity, R. R.; Goudsmit, J. Neutralization of HIV\u20101: a paradox of humoral proportions.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    5: 2437\u20132455; 1991.\n                  <\/jats:p>","DOI":"10.1096\/fasebj.5.10.1712328","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T05:12:26Z","timestamp":1516857146000},"page":"2437-2455","source":"Crossref","is-referenced-by-count":117,"title":["Neutralization of HIV\u20101: a paradox of humoral proportions"],"prefix":"10.1096","volume":"5","author":[{"given":"Peter L.","family":"Nara","sequence":"first","affiliation":[{"name":"Laboratory of Tumor Cell Biology, Virus Biology Section National Cancer Institutes\u2010Frederick Cancer Research and Development Center Frederick Maryland 21702\u20131201 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Garrity","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Cell Biology, Virus Biology Section National Cancer Institutes\u2010Frederick Cancer Research and Development Center Frederick Maryland 21702\u20131201 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Goudsmit","sequence":"additional","affiliation":[{"name":"Human Retrovirus Laboratory Academic Medical Center Amsterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1991,7]]},"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.5.10.1712328","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.5.10.1712328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:50:41Z","timestamp":1761670241000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.5.10.1712328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,7]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1991,7]]}},"alternative-id":["10.1096\/fasebj.5.10.1712328"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.5.10.1712328","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,7]]}}}